A Federal District Court judge took med-tech investors and spectators by surprise earlier this month by ordering a preliminary injunction on the U.S. sales of Medtronic's (Minneapolis) CoreValve transcatheter aortic valve replacement (TAVR/TAVI) system. The case took a turn in Medtronic's favor this week as the Federal Circuit Court of Appeals granted the company's request to postpone the implementation of the injunction. Read More
